Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
44.23
-1.06 (-2.34%)
At close: Mar 9, 2026, 4:00 PM EDT
44.50
+0.27 (0.61%)
After-hours: Mar 9, 2026, 4:37 PM EDT
Scholar Rock Holding Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
289
Market Cap
5.08B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PTC Therapeutics | 1.73B |
| Caris Life Sciences | 812.03M |
| Mirum Pharmaceuticals | 521.31M |
| Xenon Pharmaceuticals | 7.50M |
| CG Oncology | 4.04M |
| CRISPR Therapeutics AG | 3.51M |
SRRK News
- 6 days ago - Scholar Rock Holding Corporation (SRRK) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 6 days ago - Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 19 days ago - Scholar Rock to Present at Upcoming Investor Conferences - Business Wire
- 24 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 27 days ago - Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 - Business Wire
- 2 months ago - Scholar Rock Holding Corporation (SRRK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Scholar Rock Highlights 2026 Strategic Priorities - Business Wire